A new study on polycystic ovary syndrome among college students in Kashmir deserves far more than a passing news headline. Its findings expose a serious public-health concern and an equally troubling failure of awareness. Of the 1,217 students surveyed, 33.6 per cent showed symptoms suggestive of PCOS, while 1.28 per cent displayed strong indicators of the condition. Though these figures do not represent clinically confirmed prevalence, they are significant enough to demand an organised institutional response. PCOS is often reduced to irregular periods, weight gain, acne or fertility concerns. Such a narrow understanding is dangerous. The disorder can affect ovulation and reproductive health, but it is also linked to insulin resistance, diabetes and potentially cardiovascular complications. The study shows that only 44.5 per cent of students knew about its association with insulin resistance, around 45 per cent were aware of the diabetes connection, and just 33 per cent knew of its possible link with heart disease. This knowledge deficit cannot be dismissed as a minor educational gap. The silence surrounding menstrual and hormonal health makes the problem worse. In many families and institutions, menstrual irregularities are normalised, ignored or discussed only in whispers. Young women may endure symptoms for years without consultation, either because they lack information or fear social judgement. A condition that requires medical attention is too often treated as an inconvenience that must simply be tolerated. Colleges, therefore, must become an important first line of awareness and early intervention. Regular health-education sessions, confidential counselling, access to qualified medical professionals and referral systems can help students recognise warning signs without stigma. Such programmes should not be limited to reproductive health. They must explain the metabolic consequences of PCOS, the importance of lifestyle management and the need for sustained monitoring. Healthcare institutions also have a responsibility to make diagnosis accessible, affordable and respectful. Screening initiatives must be clinically guided and should never turn a questionnaire-based indication into a diagnosis. At the same time, the caution against overinterpreting the study must not become an excuse for inaction. A symptom signal affecting one in three participants is too serious to ignore. The government, universities and health authorities should now collaborate on a Kashmir-wide strategy for adolescent and young women’s health. Menstrual health must be brought into mainstream public-health planning, with special attention to counselling, nutrition, physical activity and early medical consultation. PCOS is not merely a private women’s issue. It is a public-health challenge that affects families, education, productivity and the future wellbeing of a generation. Ignoring it will deepen the burden; informed, compassionate and timely action can prevent that burden from becoming heavier.
